I hope that's the eventual result. It's extremely cynical for OTC Markets to allow unsolicited trading in nearly every one of its new "Expert" issuers.
And I think they should be stopped from doing that.
After all, on the form that has to be filled out--by whom, nowadays--in order for a stock to be quoted on an unsolicited basis, it says:
OTC Markets, as a matter of policy, does not believe that the Unsolicited Quote Exemption should be used to circumvent the FINRA Form 211 process.
That policy seems to have been thrown out the window.